دورية أكاديمية

Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.

التفاصيل البيبلوغرافية
العنوان: Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.
المؤلفون: Schroy PC 3rd; Department of Medicine, Boston University, Boston, MA, USA. paul.schroy@bmc.org, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvaganam SR, Coe AM, Chen CA, Chaisson CE, Pignone MP, Prout MN, Davidson PK, Heeren TC
المصدر: American journal of preventive medicine [Am J Prev Med] 2012 Dec; Vol. 43 (6), pp. 573-83.
نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8704773 Publication Model: Print Cited Medium: Internet ISSN: 1873-2607 (Electronic) Linking ISSN: 07493797 NLM ISO Abbreviation: Am J Prev Med Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier Science
Original Publication: [New York, NY] : Oxford University Press, [c1985-
مواضيع طبية MeSH: Decision Making* , Decision Support Techniques*, Colorectal Neoplasms/*diagnosis , Mass Screening/*methods, Aged ; Community Health Centers ; Female ; Hospitals, Urban ; Humans ; Logistic Models ; Male ; Middle Aged ; Patient Acceptance of Health Care ; Risk Assessment/methods
مستخلص: Background: Shared decision making (SDM) is a widely recommended yet unproven strategy for increasing colorectal cancer (CRC) screening uptake. Previous trials of decision aids to increase SDM and CRC screening uptake have yielded mixed results.
Purpose: To assess the impact of decision aid-assisted SDM on CRC screening uptake.
Design: RCT.
Setting/participants: The study was conducted at an urban, academic safety-net hospital and community health center between 2005 and 2010. Participants were asymptomatic, average-risk patients aged 50-75 years due for CRC screening.
Intervention: Study participants (n=825) were randomized to one of two intervention arms (decision aid plus personalized risk assessment or decision aid alone) or control arm. The interventions took place just prior to a routine office visit with their primary care providers.
Main Outcome Measures: The primary outcome was completion of a CRC screening test within 12 months of the study visit. Logistic regression was used to identify predictors of test completion and mediators of the intervention effect. Analysis was completed in 2011.
Results: Patients in the decision-aid group were more likely to complete a screening test than control patients (43.1% vs 34.8%, p=0.046) within 12 months of the study visit; conversely, test uptake for the decision aid and decision aid plus personalized risk assessment arms was similar (43.1% vs 37.1%, p=0.15). Assignment to the decision-aid arm (AOR=1.48, 95% CI=1.04, 2.10), black race (AOR=1.52, 95% CI=1.12, 2.06) and a preference for a patient-dominant decision-making approach (AOR=1.55, 95% CI=1.02, 2.35) were independent determinants of test completion. Activation of the screening discussion and enhanced screening intentions mediated the intervention effect.
Conclusions: Decision aid-assisted SDM has a modest impact on CRC screening uptake. A decision aid plus personalized risk assessment tool is no more effective than a decision aid alone.
Trial Registration: This study is registered at www.clinicaltrials.govNCT00251862.
(Copyright © 2012 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.)
References: Ann Behav Med. 2011 Dec;42(3):294-303. (PMID: 21826576)
Ann Intern Med. 2008 Nov 4;149(9):627-37. (PMID: 18838716)
J Gen Intern Med. 2009 Nov;24(11):1228-35. (PMID: 19763699)
Prev Med. 2009 Nov;49(5):442-8. (PMID: 19747502)
Patient Educ Couns. 2008 Dec;73(3):526-35. (PMID: 18752915)
Ann Intern Med. 2006 Dec 19;145(12):895-900. (PMID: 17179058)
Gastroenterol Res Pract. 2012;2012:895807. (PMID: 22272194)
Med Decis Making. 2011 Jan-Feb;31(1):93-107. (PMID: 20484090)
Patient Educ Couns. 2010 Sep;80(3):358-63. (PMID: 20667678)
Arch Intern Med. 2011 Apr 11;171(7):636-41. (PMID: 21149743)
Am J Prev Med. 2004 Jan;26(1):67-80. (PMID: 14700715)
BMC Med Inform Decis Mak. 2005 Nov 28;5:36. (PMID: 16313676)
Patient Educ Couns. 2005 Jun;57(3):294-9. (PMID: 15893211)
J Gen Intern Med. 2011 Mar;26(3):251-8. (PMID: 21088920)
Am J Prev Med. 2004 Jan;26(1):56-66. (PMID: 14700714)
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):45-52. (PMID: 22068288)
J Gen Intern Med. 2001 Dec;16(12):822-30. (PMID: 11903761)
Med Decis Making. 2002 Mar-Apr;22(2):125-39. (PMID: 11958495)
Cancer. 2007 Nov 1;110(9):2083-91. (PMID: 17893869)
Med Care. 2008 Sep;46(9 Suppl 1):S10-6. (PMID: 18725820)
Arch Gen Psychiatry. 2002 Oct;59(10):877-83. (PMID: 12365874)
Ann Behav Med. 2011 Jun;41(3):284-99. (PMID: 21271365)
Cancer. 2010 Feb 1;116(3):544-73. (PMID: 19998273)
Value Health. 2007 Sep-Oct;10(5):415-30. (PMID: 17888107)
Soc Sci Med. 1999 Sep;49(5):651-61. (PMID: 10452420)
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD001431. (PMID: 21975733)
Arch Intern Med. 2009 Feb 23;169(4):364-71. (PMID: 19237720)
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. (PMID: 22237781)
Clin Trials. 2009 Dec;6(6):597-609. (PMID: 19933718)
Am J Prev Med. 2011 Jun;40(6):608-15. (PMID: 21565651)
J Med Screen. 2008;15(2):76-82. (PMID: 18573775)
Am J Manag Care. 2007 Jul;13(7):393-400. (PMID: 17620034)
BMJ. 2010 Oct 26;341:c5370. (PMID: 20978060)
Health Expect. 2014 Feb;17(1):27-35. (PMID: 21902773)
Cancer. 2004 Sep 1;101(5 Suppl):1214-28. (PMID: 15316908)
Health Expect. 2000 Sep;3(3):182-191. (PMID: 11281928)
Prev Med. 2007 Oct;45(4):267-73. (PMID: 17689600)
Ann Intern Med. 2000 Nov 21;133(10):761-9. (PMID: 11085838)
J Gen Intern Med. 1999 Jul;14(7):432-7. (PMID: 10417601)
MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):884-9. (PMID: 21734636)
Ann Intern Med. 2002 Jul 16;137(2):129-31. (PMID: 12118971)
Cochrane Database Syst Rev. 2003;(1):CD001865. (PMID: 12535419)
CA Cancer J Clin. 2001 Jan-Feb;51(1):38-75; quiz 77-80. (PMID: 11577479)
CA Cancer J Clin. 2008 May-Jun;58(3):130-60. (PMID: 18322143)
Gastroenterology. 2003 Feb;124(2):544-60. (PMID: 12557158)
معلومات مُعتمدة: K05 CA129166 United States CA NCI NIH HHS; R01 HS013912 United States HS AHRQ HHS; K05CA129166 United States CA NCI NIH HHS; R01HS013912 United States HS AHRQ HHS
سلسلة جزيئية: ClinicalTrials.gov NCT00251862
تواريخ الأحداث: Date Created: 20121120 Date Completed: 20130501 Latest Revision: 20211021
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC3966107
DOI: 10.1016/j.amepre.2012.08.018
PMID: 23159252
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-2607
DOI:10.1016/j.amepre.2012.08.018